Affect Therapeutics operates a fully virtual platform for addiction and mental health treatment, delivering care directly to patients through a smartphone app. The company combines mobile technology with evidence-based clinical services to address substance use disorders including opioid, stimulant, alcohol, and cannabis use, alongside co-occurring conditions such as anxiety, depression, and trauma.
Treatment is provided by multidisciplinary care teams comprising licensed therapists, psychiatric providers, peer support specialists, and case managers. The platform integrates medication-assisted treatment for opioid use disorder, including Suboxone provision, with daily app engagement and real-time clinical decision-making to personalise ongoing support throughout recovery.
Affect positions its outpatient treatment programs as an alternative to traditional inpatient rehabilitation, delivered entirely through virtual channels in the United States.